Innogenetics

Molecular Blood Typing, Grouping and Infectious Disease NAT Market 2020: Supplier Shares by Country, Screening Assays, Companies Developing New Technologies & Products - ResearchAndMarkets.com

Wednesday, February 5, 2020 - 10:15am

The "2020 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, Companies Developing New Technologies and Products" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, Companies Developing New Technologies and Products" report has been added to ResearchAndMarkets.com's offering.
  • The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

Fujirebio Diagnostics Announces FDA Clearance of Lumipulse® G CA19-9-N Assay

Tuesday, December 17, 2019 - 1:00pm

MALVERN, Pa., Dec. 17, 2019 /PRNewswire-PRWeb/ -- Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company's Lumipulse G1200 CA19-9-N assay for testing on its LUMIPULSE G1200 immunoassay platform.

Key Points: 
  • MALVERN, Pa., Dec. 17, 2019 /PRNewswire-PRWeb/ -- Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company's Lumipulse G1200 CA19-9-N assay for testing on its LUMIPULSE G1200 immunoassay platform.
  • Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio Holdings, Inc., is the premier cancer diagnostics company and industry leader in cancer biomarker assays.
  • For more information about Fujirebio Diagnostics, please call +1 610-240-3800 or visit us at http://www.fujirebio-us.com .
  • Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD) testing.

Hungary Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 8:43pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Hong Kong Nucleic Acid Testing Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 6:52pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Thailand Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing - ResearchAndMarkets.com

Friday, October 11, 2019 - 6:48pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Mexico Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 6:43pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Hong Kong Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019 - ResearchAndMarkets.com

Friday, October 11, 2019 - 5:36pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Companies, universities and research centers developing new molecular- diagnostic technologies and products.

Iran Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 5:28pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Myanmar Nucleic Acid Testing Market for 100 Assays 2019: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Friday, October 11, 2019 - 2:47pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Chile Nucleic Acid Testing Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing - ResearchAndMarkets.com

Friday, October 11, 2019 - 2:45pm

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.

Key Points: 
  • The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.
  • The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.